Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction

NCT05698160 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-04-19

No results posted yet for this study

Summary

This study is to screen out the biomarkers and establish the model to predict coagulation dysfunction induced tigecycline

Conditions

  • Blood Coagulation Disorder

Sponsors & Collaborators

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-12-31
Completion
2025-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05698160 on ClinicalTrials.gov